183 related articles for article (PubMed ID: 34398900)
21. Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients.
Ke J; Liu XH; Jiang XF; He Z; Xiao J; Zheng B; Chen YF; Cai ZR; Zheng XB; Zou YF; Lan P; Wu XJ; Gao F
Eur J Surg Oncol; 2020 Oct; 46(10 Pt B):e62-e70. PubMed ID: 32863096
[TBL] [Abstract][Full Text] [Related]
22. Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling.
Martinez-Romero J; Bueno-Fortes S; Martín-Merino M; Ramirez de Molina A; De Las Rivas J
BMC Genomics; 2018 Dec; 19(Suppl 8):857. PubMed ID: 30537927
[TBL] [Abstract][Full Text] [Related]
23. Identification of macrophage-related molecular subgroups and risk signature in colorectal cancer based on a bioinformatics analysis.
Liu Q; Liao L
Autoimmunity; 2024 Dec; 57(1):2321908. PubMed ID: 38466182
[TBL] [Abstract][Full Text] [Related]
24. Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer.
Chen YJ; Luo SN; Dong L; Liu TT; Shen XZ; Zhang NP; Liang L
J Transl Med; 2021 Sep; 19(1):379. PubMed ID: 34488791
[TBL] [Abstract][Full Text] [Related]
25. A Prognostic Model Based on Six Metabolism-Related Genes in Colorectal Cancer.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Biomed Res Int; 2020; 2020():5974350. PubMed ID: 32953885
[TBL] [Abstract][Full Text] [Related]
26. The aging-related risk signature in colorectal cancer.
Yue T; Chen S; Zhu J; Guo S; Huang Z; Wang P; Zuo S; Liu Y
Aging (Albany NY); 2021 Feb; 13(5):7330-7349. PubMed ID: 33658390
[TBL] [Abstract][Full Text] [Related]
27. ZMYND8 expression combined with pN and pM classification as a novel prognostic prediction model for colorectal cancer: Based on TCGA and GEO database analysis.
Chen J; He Q; Wu P; Fu J; Xiao Y; Chen K; Xie D; Zhang X
Cancer Biomark; 2020; 28(2):201-211. PubMed ID: 32224527
[TBL] [Abstract][Full Text] [Related]
28. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
Fan Q; Liu B
J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
[TBL] [Abstract][Full Text] [Related]
29. Identification of Critical Genes and Five Prognostic Biomarkers Associated with Colorectal Cancer.
Huang Z; Yang Q; Huang Z
Med Sci Monit; 2018 Jul; 24():4625-4633. PubMed ID: 29973580
[TBL] [Abstract][Full Text] [Related]
30. Association between PPP2CA expression and colorectal cancer prognosis tumor marker prognostic study.
Yong L; YuFeng Z; Guang B
Int J Surg; 2018 Nov; 59():80-89. PubMed ID: 30296597
[TBL] [Abstract][Full Text] [Related]
31. [Value of prediction models for prognosis prediction of colorectal cancer: an analysis based on TCPA database].
Wen H; Shi W; Ge S; Li J; Zuo L; Liu M
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Mar; 41(3):439-446. PubMed ID: 33849837
[TBL] [Abstract][Full Text] [Related]
32. Downregulated SPINK4 is associated with poor survival in colorectal cancer.
Wang X; Yu Q; Ghareeb WM; Zhang Y; Lu X; Huang Y; Huang S; Sun Y; Lin J; Liu J; Chi P
BMC Cancer; 2019 Dec; 19(1):1258. PubMed ID: 31888570
[TBL] [Abstract][Full Text] [Related]
33. Identification of a 5-Nutrient Stress-Sensitive Gene Signature to Predict Survival for Colorectal Cancer.
Xiong J; Xiong S; Feng X; Zhang H; Su Q
Biomed Res Int; 2022; 2022():2587120. PubMed ID: 35496037
[TBL] [Abstract][Full Text] [Related]
34. Analysis of DNA methylation-driven genes for predicting the prognosis of patients with colorectal cancer.
Fu B; Du C; Wu Z; Li M; Zhao Y; Liu X; Wu H; Wei M
Aging (Albany NY); 2020 Nov; 12(22):22814-22839. PubMed ID: 33203797
[TBL] [Abstract][Full Text] [Related]
35. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
[TBL] [Abstract][Full Text] [Related]
36. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
[TBL] [Abstract][Full Text] [Related]
37. Integrated analysis of RNA-binding proteins in human colorectal cancer.
Fan X; Liu L; Shi Y; Guo F; Wang H; Zhao X; Zhong D; Li G
World J Surg Oncol; 2020 Aug; 18(1):222. PubMed ID: 32828126
[TBL] [Abstract][Full Text] [Related]
38. A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma.
Wang W; Wang L; Xie X; Yan Y; Li Y; Lu Q
BMC Cancer; 2021 Jan; 21(1):6. PubMed ID: 33402113
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive analyses of solute carrier family members identify SLC12A2 as a novel therapy target for colorectal cancer.
Chen DY; Zhang YY; Nie HH; Wang HZ; Qiu PS; Wang F; Peng YN; Xu F; Zhao Q; Zhang M
Sci Rep; 2024 Feb; 14(1):4459. PubMed ID: 38396064
[TBL] [Abstract][Full Text] [Related]
40. A Five-gene Signature for Predicting the Prognosis of Colorectal Cancer.
Hong J; Lin X; Hu X; Wu X; Fang W
Curr Gene Ther; 2021; 21(4):280-289. PubMed ID: 33045967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]